Although recent studies suggest the dysbiosis of gut microbiome in multiple system atrophy, as a contributor to dysfunctional intestinal barrier, new methods, including fecal RT-QuIC, smell testing, microbiota replacement, and gene-editing therapies, offer more promising evidence for diagnosis and disease-modifying the...